Latest news
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:30:00 GMTPrecision Medicine And Rare Disease Development Expand The Targeted Biotech Opportunity - DirectorsTalk InterviewsDirectorsTalk Interviews · Mon, 10 Aug 2026 10:35:00 GMTANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 19:01:35 GMTANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration - StockStoryStockStory · Fri, 07 Aug 2026 07:00:00 GMTGeorgia lawmakers join push to expand VA benefits for veterans with rare muscle disease - 11Alive.com11Alive.com · Tue, 04 Aug 2026 19:54:00 GMTNew Medicaid work rules could cause patients to lose coverage, rare disease advocates warn - CNBCCNBC · Fri, 31 Jul 2026 07:00:00 GMTDoes BioMarin (BMRN) Expanding Into ReNU Syndrome Refine Its Rare Disease Pipeline Strategy? - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:15:07 GMT